C.ディフィシル、C.パーフリンジェンス、メチシリン耐性黄色ブドウ球菌(MRSA)を含むブドウ球菌属、又はバンコマイシン耐性腸球菌(VRE)を含む腸球菌による大腸炎、偽膜性大腸炎、抗菌剤関連下痢、及び感染症のような抗生物質又は癌化学療法又は抗ウイルス療法の利用に関連する疾患のTiacumicin Bによる治療又は予防。 The invention relates to the treatment or prevention of disease associated with the use of antibiotics or cancer chemotherapies or antiviral therapies, such as colitis, pseudomembranous colitis, antimicrobial agent-associated diarrhea and infections due to C. difficile, C. perfringens, Staphylococcus species including methicillin-resistant Staphylococcus aureus (MRSA) or Enterococcus including vancomycin-resistant enterococci (VRE) with Tiacumicin B. - 特許庁